Francis Ball
Senior CMC Manager
Francis joined TBVI in 2026 as Senior CMC Manager. He is currently seconded to the European Vaccine Initiative (EVI), where he oversees project-specific CMC activities supporting the development of clinical-stage vaccine candidates. His work involves implementing phase-appropriate development and regulatory strategies grounded in Quality by Design (QbD) principles and aligned with pharmacopoeial standards and global regulatory expectations.
After obtaining his BSc in Biology and Biomedical Engineering at Tufts University, Francis began his career at the Center for Virology and Vaccine Research (CVVR) at Beth Israel Deaconess Medical Center (BIDMC) in Boston, where he developed novel human and simian adenovirus vaccine vectors in support of HIV-1 vaccine research and development. He later earned his MD from Jagiellonian University Medical College in Kraków, Poland, and completed his postgraduate clinical internship. Subsequently, he undertook residency training in Medical Microbiology at the University Hospital in Kraków, with a focus on molecular diagnostics and respiratory pathogen detection.
Francis went on to join a viral vaccine and vector CDMO in the Netherlands, progressing through roles as Scientist, Project Officer, Senior Scientist and Scientific Integrator. His responsibilities spanned cell bank establishment, virus seed generation and characterisation, and the integration of CMC activities across product, process and analytical domains, serving as a CMC and scientific representative in international vaccine programmes addressing global health needs.
As a physician scientist, he is committed to continuous learning and applying scientific evidence to support innovation, informed decision-making and improved public health. He believes that international collaboration and bringing together diverse expertise and perspectives are essential to the success of promising vaccine initiatives.